IL6 and colonic neoplasm: These and other studies have suggested that IL-6 monoclonal antibodies alone do not show significant anticancer effectiveness in advanced colon cancer, or in other solid tumors [25]; however, it cannot be excluded that they may be effective in the early stage of the disease.